HK1028738A1 - Water soluble dry compositions - Google Patents

Water soluble dry compositions

Info

Publication number
HK1028738A1
HK1028738A1 HK00108139A HK00108139A HK1028738A1 HK 1028738 A1 HK1028738 A1 HK 1028738A1 HK 00108139 A HK00108139 A HK 00108139A HK 00108139 A HK00108139 A HK 00108139A HK 1028738 A1 HK1028738 A1 HK 1028738A1
Authority
HK
Hong Kong
Prior art keywords
dry compositions
water soluble
amino acids
hydrophobic amino
defoaming agents
Prior art date
Application number
HK00108139A
Other languages
English (en)
Inventor
Chikamasa Yamashita
Masaaki Odomi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1028738A1 publication Critical patent/HK1028738A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK00108139A 1998-06-26 2000-12-15 Water soluble dry compositions HK1028738A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18079698 1998-06-26
PCT/JP1999/003369 WO2000000221A1 (fr) 1998-06-26 1999-06-24 Compositions seches solubles dans l'eau

Publications (1)

Publication Number Publication Date
HK1028738A1 true HK1028738A1 (en) 2001-03-02

Family

ID=16089500

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108139A HK1028738A1 (en) 1998-06-26 2000-12-15 Water soluble dry compositions

Country Status (15)

Country Link
US (2) US6337067B1 (xx)
EP (1) EP1018345B1 (xx)
JP (1) JP4332694B2 (xx)
KR (1) KR100652943B1 (xx)
CN (1) CN100341575C (xx)
AT (1) ATE416790T1 (xx)
AU (1) AU760940B2 (xx)
CA (1) CA2301889C (xx)
DE (1) DE69940051D1 (xx)
DK (1) DK1018345T3 (xx)
ES (1) ES2317695T3 (xx)
HK (1) HK1028738A1 (xx)
ID (1) ID24279A (xx)
PT (1) PT1018345E (xx)
WO (1) WO2000000221A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758794B2 (en) 2001-10-29 2010-07-20 Princeton University Method of making an article comprising nanoscale patterns with reduced edge roughness
KR100709792B1 (ko) * 1999-12-24 2007-04-19 오츠카 세이야쿠 가부시키가이샤 소수성 아미노산을 포함하는 건조 조성물
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP4610154B2 (ja) * 2002-05-30 2011-01-12 大塚製薬株式会社 注射用製剤
FR2857267B1 (fr) * 2003-07-09 2006-03-10 Lab Francais Du Fractionnement Formulation stabilisante et solubilisante pour les proteines cryoprecipitables.
US20100217664A1 (en) * 2007-09-07 2010-08-26 Ryan Steelberg Engine, system and method for enhancing the value of advertisements
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
ES2625331T3 (es) * 2009-12-21 2017-07-19 Glanbia Nutritionals (Ireland) Ltd. Composición de leucina/péptido y procedimiento de formulación
WO2013063284A1 (en) 2011-10-25 2013-05-02 Onclave Therapeutics Antibody formulations and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0168008A3 (en) 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
DE4242863A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
CN1045390C (zh) * 1994-06-16 1999-10-06 谭灿文 复合氨基酸冲剂
TW403653B (en) * 1995-12-25 2000-09-01 Otsuka Pharma Co Ltd Dry compositions

Also Published As

Publication number Publication date
ATE416790T1 (de) 2008-12-15
KR20010023269A (ko) 2001-03-26
JP4332694B2 (ja) 2009-09-16
AU4392899A (en) 2000-01-17
DE69940051D1 (de) 2009-01-22
US6479048B2 (en) 2002-11-12
AU760940B2 (en) 2003-05-22
KR100652943B1 (ko) 2006-12-01
WO2000000221A1 (fr) 2000-01-06
EP1018345A1 (en) 2000-07-12
CN100341575C (zh) 2007-10-10
EP1018345A4 (en) 2005-01-26
ES2317695T3 (es) 2009-04-16
US6337067B1 (en) 2002-01-08
ID24279A (id) 2000-07-13
CN1272795A (zh) 2000-11-08
WO2000000221A9 (fr) 2000-07-27
CA2301889A1 (en) 2000-01-06
EP1018345B1 (en) 2008-12-10
US20010049361A1 (en) 2001-12-06
DK1018345T3 (da) 2009-03-23
CA2301889C (en) 2008-02-19
PT1018345E (pt) 2009-01-23

Similar Documents

Publication Publication Date Title
CA2003198A1 (en) Aqueous ophthalmic solutions and method for preserving same
AU2001275305A1 (en) Rinse agent composition and method for rinsing a substrate surface
CA2209048A1 (en) Aqueous curable alkoxy silane/alkoxy silylated polymer compositions with extended shelf life
CA2198004A1 (en) Rinse aid for plasticware
AU2460488A (en) Iodine mirobicide composition
MXPA03006999A (es) Composicion limpiadora espumante suave.
CA2036283A1 (en) Effervescent composition, its production and use
HK1028738A1 (en) Water soluble dry compositions
WO2002026277A3 (en) Stabilized hydrogen peroxide solutions
WO1999017711A3 (en) Autophobic hairspray compositions
GR3003622T3 (xx)
IL117127A0 (en) Microemulsion compositions of 3-isothiazolone compounds
CA2213894A1 (en) Corrosion inhibiting composition
IL137400A0 (en) Solid fuel additive
AU3139799A (en) Integrated additive composition, process for its preparation and its use
WO2003048342A3 (en) Liquid yeast compositions
ATE205386T1 (de) Einphasige,transparente wässrige zusammensetzung
AU3546597A (en) Stabilised and buffered hydrogen peroxide solution, method for making same and use thereof for decontaminating contact lenses
AU6255994A (en) Stabilised food composition
WO2000021577A3 (en) Compositions
NO943373D0 (no) Psyliumholdig sammensatt blandingsdrikk
CA2013474A1 (en) Cyclophosphamide - alanine lyophilizates
FR2732354B1 (fr) Composition a recurer se presentant sous forme liquide ou de creme
TH20636B (th) สารต้านเชื้อราแบบผสม
CA2183745A1 (en) Detergent Compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160624